Life Molecular patents expiration

1. Neuraceq patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US7907135 LIFE MOLECULAR Image display and image displaying method for gradation correction
Mar, 2029

(4 years from now)

US7807135 LIFE MOLECULAR Stilbene derivatives and their use for binding and imaging amyloid plaques
Mar, 2029

(4 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Chemical Entity Exclusivity(NCE) Mar 21, 2019

Drugs and Companies using FLORBETABEN F-18 ingredient

NCE-1 date: 21 March, 2018

Market Authorisation Date: 19 March, 2014

Treatment: Neuraceq is a radioactive diagnostic agent for positron emission tomography (pet) imaging of the brain to estimate p-amyloid neuritic plaque density in adult patients with cognitive impairment


More Information on Dosage

NEURACEQ family patents

Family Patents